International Company For Medical Industries S.A.E. (EGX:FCMD)

EGX:FCMD Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.25	9.33	2.07	9.76	34.32	0.09
Cash & Short-Term Investments	0.25	9.33	2.07	9.76	34.32	0.09
Cash Growth	-58.01%	350.42%	-78.77%	-71.55%	37593.98%	-83.51%
Accounts Receivable	11.29	7.76	8.46	8	-	0.68
Other Receivables	2.44	3	15.42	16.63	9.96	8.57
Receivables	18.39	12.23	23.87	26.65	11.56	10.86
Inventory	23.9	21.24	15.54	12.09	5.98	6.06
Prepaid Expenses	0.14	-	1.91	-	-	-
Other Current Assets	0.9	0.58	0.78	0.4	0.08	0.07
Total Current Assets	43.58	43.39	44.17	48.91	51.94	17.08
Property, Plant & Equipment	47.67	49.85	41.07	9.93	9.86	11.75
Long-Term Investments	-	-	-	6.15	6.15	6.15
Goodwill	17.89	18.86	18.86	-	-	-
Other Long-Term Assets	-	-	-0	-	-	-
Total Assets	109.14	112.1	104.1	64.99	67.95	34.98

Liabilities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Accounts Payable	17.88	10.5	3.89	1.71	-	0.1
Accrued Expenses	5.64	3.03	2.55	0.43	0.07	0.15
Short-Term Debt	5.03	5.14	4.86	0.52	2.27	2.32
Current Portion of Long-Term Debt	2.02	2.42	-	-	-	-
Current Income Taxes Payable	1	3.5	-	0.12	0	0
Other Current Liabilities	39.76	40.05	25.17	1.01	4.72	5.52
Total Current Liabilities	71.33	64.64	36.46	3.8	7.06	8.09
Long-Term Debt	-	1.41	6.26	-	-	-
Long-Term Deferred Tax Liabilities	1.49	0.25	0.25	0.5	0.55	0.51
Other Long-Term Liabilities	-	-	-0	-	-	0
Total Liabilities	72.81	66.31	42.98	4.3	7.61	8.6

Shareholders' Equity

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Common Stock	57.67	57.67	57.67	57.67	24.19	24.19
Retained Earnings	-24.3	-17.15	1.73	3.01	2.09	2.19
Comprehensive Income & Other	-	0	-	0	34.05	0
Total Common Equity	33.38	40.52	59.4	60.68	60.34	26.38
Minority Interest	2.95	5.27	1.72	-	-	-
Shareholders' Equity	36.33	45.79	61.12	60.68	60.34	26.38
Total Liabilities & Equity	109.14	112.1	104.1	64.99	67.95	34.98

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Debt	7.05	8.98	11.13	0.52	2.27	2.32
Net Cash (Debt)	-6.8	0.35	-9.05	9.24	32.05	-2.22
Net Cash Growth	-	-	-	-71.18%	-	-
Net Cash Per Share	-0.12	0.01	-0.16	0.16	1.33	-0.09
Filing Date Shares Outstanding	57.67	57.67	57.67	57.67	24.19	24.19
Total Common Shares Outstanding	57.67	57.67	57.67	57.67	24.19	24.19
Working Capital	-27.75	-21.25	7.71	45.11	44.88	8.99
Book Value Per Share	0.58	0.70	1.03	1.05	2.49	1.09
Tangible Book Value	15.49	21.67	40.55	60.68	60.34	26.38
Tangible Book Value Per Share	0.27	0.38	0.70	1.05	2.49	1.09
Land	7.07	7.07	7.07	2.86	2.86	2.86
Buildings	19.8	19.8	19.28	5.35	5.35	6.55
Machinery	27.93	27.72	17.99	7.62	7.25	7.25
Construction In Progress	-	-	-	0.53	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 4, 2026

Data Sources Report a data error